Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05637242 · ClinicalTrials.gov registry record
Ventricular Assist Device (VAD) Research Registry and Blood Sub-Study
A clinical trial, sponsored by Corewell Health West.
- Terminated
- Registry status
- 371
- Enrollment target
NCT05637242 is a clinical trial that was terminated before completion, run by Corewell Health West. The registered enrollment target is 371 participants.
The verdict
NCT05637242 was terminated before completion, sponsored by Corewell Health West.
- TERMINATED
- Registry status
- 371 participants
- Enrollment target
Study Summary
This study is meant to predict the outcome of VAD therapy, by forming a VAD registry for quality assessment, research, and real-time monitoring of patients on VAD therapy. The goal is to optimize the use of VAD therapy for patients, to create an online quality measurement tool for VAD treatment, and to create algorithms to estimate the prognosis for patients getting a VAD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2016-02 |
| Est. Completion | 2024-05-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05637242
The ClinicalTrials.gov registry entry for NCT05637242 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 371 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05637242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05637242 about?
NCT05637242 is a clinical study titled "Ventricular Assist Device (VAD) Research Registry and Blood Sub-Study". This study is meant to predict the outcome of VAD therapy, by forming a VAD registry for quality assessment, research, and real-time monitoring of patients on VAD therapy. The goal is to optimize the use of VAD therapy for patients, to create an online quality measurement tool for VAD treatment, and...
What is the current status of trial NCT05637242?
This trial is currently terminated. The enrollment target is 371 participants. The study started on 2016-02. Estimated completion is 2024-05-29.
Who is sponsoring clinical trial NCT05637242?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.